PAR paradigm biopharmaceuticals limited..

Ann: Half Yearly Report and Accounts, page-3

  1. 111 Posts.
    lightbulb Created with Sketch. 78
    Very happy to see that

    '(A) New batch of iPPS (Zilosul®) has been manufactured to ensure sufficient product for Paradigm’s clinical trial and user-pays TGA SAS'

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
46.5¢
Change
0.010(2.20%)
Mkt cap ! $184.8M
Open High Low Value Volume
45.5¢ 48.0¢ 44.0¢ $534.2K 1.168M

Buyers (Bids)

No. Vol. Price($)
1 5245 45.5¢
 

Sellers (Offers)

Price($) Vol. No.
47.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 04/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.